These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1168705)
21. Investigation of various factors affecting encapsulation on the in-cap automatic capsule-filling machine. Nair R; Vemuri M; Agrawala P; Kim SI AAPS PharmSciTech; 2004 Oct; 5(4):e57. PubMed ID: 15760054 [TBL] [Abstract][Full Text] [Related]
22. Malacymeter, an apparatus for the determination of the softness on soft gelatin dosage forms. Colombo BM Boll Chim Farm; 1969 Dec; 108(12):810-3. PubMed ID: 5374888 [No Abstract] [Full Text] [Related]
23. The influence of additives on the presentation of a drug in hard gelatin capsules. Newton JM; Razzo FN J Pharm Pharmacol; 1977 May; 29(5):294-7. PubMed ID: 17694 [TBL] [Abstract][Full Text] [Related]
24. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules. Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554 [TBL] [Abstract][Full Text] [Related]
25. Development of a colon delivery capsule and the pharmacological activity of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in beagle dogs. Takaya T; Ikeda C; Imagawa N; Niwa K; Takada K J Pharm Pharmacol; 1995 Jun; 47(6):474-8. PubMed ID: 7545751 [TBL] [Abstract][Full Text] [Related]
26. Development and Characterisation of Modified Release Hard Gelatin Capsules, Based on In Situ Lipid Matrix Formation. Vasvári G; Csontos B; Sovány T; Regdon G; Bényei A; Váradi J; Bácskay I; Ujhelyi Z; Fehér P; Sinka D; Nguyen TLP; Vecsernyés M; Fenyvesi F AAPS PharmSciTech; 2018 Oct; 19(7):3165-3176. PubMed ID: 30136176 [TBL] [Abstract][Full Text] [Related]
27. Imprinting on empty hard gelatin capsule shells containing titanium dioxide by application of the UV laser printing technique. Hosokawa A; Kato Y; Terada K Drug Dev Ind Pharm; 2014 Aug; 40(8):1047-53. PubMed ID: 23786207 [TBL] [Abstract][Full Text] [Related]
28. Physicochemical properties and controlled drug release of microcapsules prepared by simple coacervation. Shimokawa K; Saegusa K; Wada Y; Ishii F Colloids Surf B Biointerfaces; 2013 Apr; 104():1-4. PubMed ID: 23298580 [TBL] [Abstract][Full Text] [Related]
29. Ease of oral administration and owner-perceived acceptability of triglyceride oil, dissolving thin film strip, and gelatin capsule formulations to healthy cats. Traas AM; Fleck T; Ellings A; Mahabir S; Stuebner K; Brown DC; Durso D; DiGregorio M; Bode L; Kievit KI; McCall R Am J Vet Res; 2010 Jun; 71(6):610-4. PubMed ID: 20513174 [TBL] [Abstract][Full Text] [Related]
30. A novel collagenase-assisted extraction of active pharmaceutical ingredients from gelatin products for quantitative analysis by high performance liquid chromatography. Zhao C; Furukawa S; Ohki Y J Chromatogr A; 2009 May; 1216(20):4524-8. PubMed ID: 19344904 [TBL] [Abstract][Full Text] [Related]
31. New formula herbal pellets demonstrate a uniform and stable release of the active ingredients in vitro. Pranskuniene Z; Bernatoniene J; Kalveniene Z; Masteikova R; Mekas T; Velziene S; Ivanauskas K; Suchockas V; Mintauckiene I; Savickas A Acta Pol Pharm; 2013; 70(4):727-36. PubMed ID: 23923396 [TBL] [Abstract][Full Text] [Related]
32. Characterisation of transmission Raman spectroscopy for rapid quantitative analysis of intact multi-component pharmaceutical capsules. Hargreaves MD; Macleod NA; Smith MR; Andrews D; Hammond SV; Matousek P J Pharm Biomed Anal; 2011 Feb; 54(3):463-8. PubMed ID: 20947277 [TBL] [Abstract][Full Text] [Related]
33. Gastrointestinal release site for delayed release and gelatin capsules in healthy dogs. Stone CB; Rudinsky AJ; Urion RJ; March SB; Winston JA J Vet Pharmacol Ther; 2024 Jul; 47(4):266-273. PubMed ID: 38519447 [TBL] [Abstract][Full Text] [Related]
34. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study. M K; Sistla R; Shastri NR Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823 [TBL] [Abstract][Full Text] [Related]
35. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules. Gohil UC; Podczeck F; Turnbull N Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679 [TBL] [Abstract][Full Text] [Related]
36. Construction of an intermittent-motion capsule filling machine simulator. Britten JR; Barnett MI; Armstrong NA Pharm Res; 1995 Feb; 12(2):196-200. PubMed ID: 7784333 [TBL] [Abstract][Full Text] [Related]
37. Simultaneous detection of bovine and porcine DNA in pharmaceutical gelatin capsules by duplex PCR assay for Halal authentication. Nikzad J; Shahhosseini S; Tabarzad M; Nafissi-Varcheh N; Torshabi M Daru; 2017 Feb; 25(1):3. PubMed ID: 28196517 [TBL] [Abstract][Full Text] [Related]
38. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules. Adesunloye TA; Stach PE Drug Dev Ind Pharm; 1998 Jun; 24(6):493-500. PubMed ID: 9876614 [TBL] [Abstract][Full Text] [Related]
39. Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule. Stella V; Haslam J; Yata N; Okada H; Lindenbaum S; Higuchi T J Pharm Sci; 1978 Oct; 67(10):1375-7. PubMed ID: 702283 [TBL] [Abstract][Full Text] [Related]
40. [Natural biopolymers as excipients in medicinal product dosage form. Part I. Soft gelatin capsules as a modern and elegant pharmaceutical dosage form]. Dobrzyński ŁJ; Zgoda MM Polim Med; 2010; 40(2):11-9. PubMed ID: 20649085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]